Company · CIK 0001694665
Evelo Biosciences, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-24-016885 · 204.5 KBSEC(opens sec.gov)
- SC 13G/AEvelo Biosciences, Inc.0000315066-23-002794 · 7.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-287901 · 165.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001694665-23-000186 · 227.1 KBSEC(opens sec.gov)
- SC 13G/AEvelo Biosciences, Inc.0000315066-23-002746 · 8.0 KBSEC(opens sec.gov)
- 10-QQuarterly update0001694665-23-000182 · 6.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-23-265281 · 221.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001694665-23-000163 · 181.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001694665-23-000150 · 229.9 KBSEC(opens sec.gov)
- 10-QQuarterly update0001694665-23-000146 · 6.0 MBSEC(opens sec.gov)
Insiders
- AFEYAN NOUBAR10% Owner
- Alexandria Venture Investments, LLC10% Owner
- Andres JuanDirector
- Bodmer MarkCSO, President of R&D
- CARRIERE STEPHEN JPrincipal Accounting Officer
- Char DanielGeneral Counsel
- Darzi Lord AraDirector
- Epstein David RDirector
- Flagship Pioneering Fund VII, L.P.10% Owner
- Flagship Pioneering, LLC10% Owner
Tickers
No tickers on record.
Addresses
business
124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035
mailing
124 WASHINGTON STREET, SUITE 101
FOXBORO, MA, 02035
Same industry